Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Bouche

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 27, 2021
Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosisKoceila Amroun, Vincent Scholer, Zoubir Djerada, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 8, 2021
A case of palmar hypopigmentation induced by capecitabine in a gastrointestinal cancer patientJulian Gratiaux, Chloé Gossery, Chirine Rezzag-Mahcene, et al.
Melanoma Research|February 15, 2026
Determinants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3Aurore Devoldere, Olivier Bouche, Coralie Barbe, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 6, 2026
Characterisation of early-onset pancreatic adenocarcinoma molecular profile compared to average-onset pancreatic adenocarcinoma (CARAPAC): A systematic review and a meta-analysisMathias Brugel, Vivien Riviere, Audrey Hubert, et al.
Anticancer Research|November 1, 2016
Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction AdenocarcinomaNathalie Lemoine, Antoine Adenis, Olivier Bouche, et al.
Gastroenterologie Clinique Et Biologique|July 25, 2007
Outcome after surgical treatment of gastrointestinal stromal tumorsAnne-Géraldine Weber, Nicolas Jovenin, Denis Lubrano, et al.
Anticancer Research|July 9, 2011
Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancerOlivier Bouche, Frederique Maindrault-Goebel, Michel Ducreux, et al.
Surgical Endoscopy|February 21, 2020
Fully laparoscopic thermo-ablation of liver malignancies with or without liver resection: tumor location is an independent local recurrence risk factorGeoffrey Ledoux, Koceila Amroun, Rami Rhaiem, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients - A post-hoc analysis of the PETACC 8 trialElisabeth Sophie Bergen, Clémence Canton, Mathieu Boulin, et al.
Journal of Pain and Symptom Management|August 30, 2008
Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancerS Gail Eckhardt, Peter De Porre, David Smith, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 27, 2021
Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosisKoceila Amroun, Vincent Scholer, Zoubir Djerada, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 8, 2021
A case of palmar hypopigmentation induced by capecitabine in a gastrointestinal cancer patientJulian Gratiaux, Chloé Gossery, Chirine Rezzag-Mahcene, et al.
Melanoma Research|February 15, 2026
Determinants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3Aurore Devoldere, Olivier Bouche, Coralie Barbe, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 6, 2026
Characterisation of early-onset pancreatic adenocarcinoma molecular profile compared to average-onset pancreatic adenocarcinoma (CARAPAC): A systematic review and a meta-analysisMathias Brugel, Vivien Riviere, Audrey Hubert, et al.
Anticancer Research|November 1, 2016
Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction AdenocarcinomaNathalie Lemoine, Antoine Adenis, Olivier Bouche, et al.
Gastroenterologie Clinique Et Biologique|July 25, 2007
Outcome after surgical treatment of gastrointestinal stromal tumorsAnne-Géraldine Weber, Nicolas Jovenin, Denis Lubrano, et al.
Anticancer Research|July 9, 2011
Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancerOlivier Bouche, Frederique Maindrault-Goebel, Michel Ducreux, et al.
Surgical Endoscopy|February 21, 2020
Fully laparoscopic thermo-ablation of liver malignancies with or without liver resection: tumor location is an independent local recurrence risk factorGeoffrey Ledoux, Koceila Amroun, Rami Rhaiem, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients - A post-hoc analysis of the PETACC 8 trialElisabeth Sophie Bergen, Clémence Canton, Mathieu Boulin, et al.
Journal of Pain and Symptom Management|August 30, 2008
Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancerS Gail Eckhardt, Peter De Porre, David Smith, et al.
Pageof 5